ANTHONY DIGIANDOMENICO Insider Trading $NDRA ENDRA Life Sciences Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ANTHONY DIGIANDOMENICO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ANTHONY DIGIANDOMENICO. ANTHONY DIGIANDOMENICO is Director in Cue Biopharma, Inc. ($CUE) and in ENDRA Life Sciences Inc. ($NDRA) and Director in ENDRA Life Sciences Inc. ($NDRA) and Director in Provention Bio, Inc. ($PRVB).
ANTHONY DIGIANDOMENICO in ENDRA Life Sciences Inc.
Industry: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
Position of ANTHONY DIGIANDOMENICO: Director
Holdings: 382,012 shares
Latest Transaction: Apr 07 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ANTHONY DIGIANDOMENICO in ENDRA Life Sciences Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CUE, NDRA, PRVB
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 07 2021 | NDRA | ENDRA Life Science ... | DIGIANDOMENICO ANTHONY | Director | Option Exercise | A | 2.64 | 25,000 | 66,000 | 25,000 | |
| Jul 23 2020 | NDRA | ENDRA Life Science ... | DIGIANDOMENICO ANTHONY | Director | Option Exercise | X | 0.87 | 100,503 | 87,438 | 0 | |
| Jul 23 2020 | NDRA | ENDRA Life Science ... | DIGIANDOMENICO ANTHONY | Director | Buy | X | 0.87 | 100,503 | 87,438 | 382,012 | 281.5 K to 382 K (+35.70 %) |
| Jun 09 2020 | NDRA | ENDRA Life Science ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 0.92 | 5,000 | 4,600 | 281,509 | 276.5 K to 281.5 K (+1.81 %) |
| May 29 2020 | NDRA | ENDRA Life Science ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 0.90 | 5,000 | 4,500 | 276,509 | 271.5 K to 276.5 K (+1.84 %) |
| May 26 2020 | NDRA | ENDRA Life Science ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 0.78 | 10,000 | 7,800 | 252,083 | 242.1 K to 252.1 K (+4.13 %) |
| Apr 13 2020 | NDRA | ENDRA Life Science ... | DIGIANDOMENICO ANTHONY | Director | Grant | A | 0.00 | 42,857 | 0 | 242,083 | 199.2 K to 242.1 K (+21.51 %) |
| Jan 06 2020 | NDRA | ENDRA Life Science ... | DIGIANDOMENICO ANTHONY | Director | Option Exercise | A | 1.90 | 12,000 | 22,800 | 12,000 | |
| Dec 11 2019 | NDRA | ENDRA Life Science ... | DIGIANDOMENICO ANTHONY | Director | Option Exercise | A | 0.87 | 100,503 | 87,438 | 100,503 | |
| Dec 11 2019 | NDRA | ENDRA Life Science ... | DIGIANDOMENICO ANTHONY | Director | Option Exercise | A | 0.90 | 89,585 | 80,627 | 89,585 | |
| Dec 11 2019 | NDRA | ENDRA Life Science ... | DIGIANDOMENICO ANTHONY | Director | Grant | A | 0.87 | 100,503 | 87,438 | 199,226 | 98.7 K to 199.2 K (+101.80 %) |
| Mar 27 2019 | NDRA | ENDRA Life Science ... | DIGIANDOMENICO ANTHONY | Director | Option Exercise | A | 3.09 | 50,000 | 154,500 | 50,000 | |
| Nov 15 2018 | NDRA | ENDRA Life Science ... | DIGIANDOMENICO ANTHONY | Director | Buy | C | 1.68 | 59,524 | 100,000 | 118,149 | 58.6 K to 118.1 K (+101.53 %) |
| Jul 02 2018 | NDRA | ENDRA Life Science ... | DIGIANDOMENICO ANTHONY | Director | Option Exercise | A | 2.52 | 24,802 | 62,501 | 24,802 | |
| Jul 02 2018 | NDRA | ENDRA Life Science ... | DIGIANDOMENICO ANTHONY | Director | Option Exercise | A | 2.52 | 24,802 | 62,501 | 24,802 | |
| Jan 04 2018 | NDRA | ENDRA Life Science ... | DIGIANDOMENICO ANTHONY | Option Exercise | A | 4.95 | 6,061 | 30,002 | 6,061 | ||
| May 19 2017 | NDRA | ENDRA Life Science ... | DIGIANDOMENICO ANTHONY | Director | Option Exercise | A | 5.00 | 12,000 | 60,000 | 12,000 | |
| May 19 2017 | NDRA | ENDRA Life Science ... | DIGIANDOMENICO ANTHONY | Director | Buy | C | 1.40 | 19,426 | 27,196 | 58,625 | 39.2 K to 58.6 K (+49.56 %) |
Page: 1